Conformal Medical announced “encouraging” results when comparing its CLAAS implant to the Boston Scientific Watchman FLX. These left atrial appendage occlusion (LAAO) devices bring different things to the table. Made of foam, CLAAS features a cup design with an embedded nitinol skeleton covered by a fluoropolymer (ePTFE) cover. Watchman FLX’s nitinol frame is covered by […]
Conformal Medical
The biggest cardiovascular stories from TCT 2023
Every year, some of the biggest names in cardiovascular technologies come together in one place for TCT. This year’s 35th edition of the Transcatheter Cardiovascular Therapeutics annual scientific symposium was no different in San Francisco. Usual suspects like Medtronic and Abbott released data covering a range of products, while other big names like Edwards, GE […]
Study backs left atrial appendage occlusion device from Conformal Medical
Conformal Medical announced positive one-year results from an early feasibility study of its left atrial appendage occlusion (LAAO) device. Nashua, New Hampshire-based Conformal shared the data at the 35th Transcatheter Cardiovascular Therapeutics (TCT) in San Francisco. Dr. William Gray presented the “Conformal CLAAS LAAO Device EFS 1-Year TEE Follow-Up.” “I am pleased to report that […]
Conformal Medical raises $35M in oversubscribed Series D
Conformal Medical today announced the successful completion of its Series D funding round, where it raised a total of $35 million. The oversubscribed Series D was led by Sprig Equity, with participation from all major Series C investors. “Sprig Equity is focused on enabling transformative medical technology companies to achieve meaningful milestones and, more importantly, […]
Study supports left atrial appendage sealing implant from Conformal Medical
Conformal Medical announced today that results from an early feasibility study support the use of its CLAAS implant for reducing stroke risk. Nashua, New Hampshire–based Conformal’s study evaluated angiography compared to transesophageal echocardiogram (TEE) in left atrial appendage (LAA) assessment. Dr. William Gray presented findings at Cardiovascular Research Technologies Conference (CRT 2023) in Washington, D.C. […]
Conformal Medical raises $70 million
Stroke prevention technology developer Conformal Medical filed an SEC Form D to confirm the sale of $70 million in an equity offering. Nashua, N.H.-based Conformal Medical is offering $85 million in equity in total, leaving $15 million left to be sold. It made the first sale in the new notice offering on July 24 and […]
DTW: What in the world will Thrive Earlier Detection do with $257 million?
In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Dr. Isaac Kinde, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical […]
Conformal Medical launches LAA seal study
Conformal Medical said yesterday that it launched an investigational device exemption trial for a device designed to seal off the heart’s left atrial appendage to help prevent stroke in atrial fibrillation patients. Nashua, N.H.-based Conformal’s device is designed to adapt to the each patient’s individual physiology, to be easier to implant with less imaging and […]
Conformal Medical raises $9m Series B for anti-stroke cardiac implant
Conformal Medical said today that it raised $9 million in a Series B round for the anti-stroke cardiac implant it’s developing. Nashua, N.H.-based Conformal is working on a left atrial appendage seal to prevent stroke in atrial fibrillation patients. It’s designed to adapt to the each patient’s individual physiology, to be easier to implant with less imaging […]